Core Innovation Capital

What Core Innovation Capital does

Core Innovation Capital is a Los Angeles-based venture capital firm founded in 2010 that invests seed and Series A capital, typically $1–5 million per company, into early-stage fintech and healthtech startups. The firm originated as the investment vehicle of the Financial Health Network, giving it institutional reach into nonprofits, regulators, and incumbent financial institutions that few seed-stage peers command. Its stated mission targets $1 trillion in new wealth and cost savings for 77 million underserved Americans, and the active portfolio spans more than 60 companies across consumer finance, financial infrastructure, and digital health.

The firm competes for deal flow and limited partners by combining thematic specialization with senior operating and regulatory talent — most notably former Acting Comptroller of the Currency Michael Hsu as Venture Partner, alongside partners with earned-wage, fintech infrastructure, and consumer finance operating backgrounds. Core Innovation Capital has formalized artificial intelligence as a cross-portfolio capability through a dedicated AI Tech Lead and has built internal tools such as a VoiceAI navigation surface and an investor portal. Co-investment syndicates in 2025 included Allianz Life Ventures, Mouro Capital, FJ Labs, and SUM Ventures, indicating expanded relationships with insurance incumbents and global fintech specialists.

The business model follows the standard venture capital structure: management fees on committed or invested capital across fund vintages, supplemented by carried interest on realized exits. With a small partnership and a mission-driven LP value proposition anchored in measurable financial-health outcomes, the firm differentiates itself in fundraising against generalist seed funds. Growth signals are modest but positive — sequential senior hires through 2023 and 2025, a formalized AI capability, and active co-investment positioning suggest a successor fund vintage rather than a step-change scale-up.

Name

Core Innovation Capital

Legal name

Core Innovation Capital

Website

https://corevc.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Core Innovation Capital is a Los Angeles-based venture capital firm that invests $1–5 million at the seed and Series A stages into fintech and healthtech startups serving mass-market Americans, supported by a 60+ company portfolio and senior regulatory talent.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industries

Financial Services / Fintech Growth Equity (FSANACAE), Technology & Software Growth Equity (FSANACAA)

Keywords

• Venture capital investing
• Fintech venture investing
• Seed to series A
• Healthtech venture capital
• Early-stage equity investing

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Venture Capital Returns: Core generates returns through equity investments in early-stage fintech and healthtech startups. Returns are realized through exits including IPOs, acquisitions, and secondary sales of portfolio companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Core Innovation Capital is a venture capital firm that invests $1-5 million in Seed to Series A companies, primarily in fintech, healthtech, insurance, real estate, and work technology. The firm takes equity positions in early-stage startups that target financial services, healthcare, insurance, real estate, and the future of work, and provides hands-on partnership and strategic guidance to help founders navigate regulated industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Core Innovation Capital (Core VC) Seed-to-Series A Equity Investment Equity investment offering where Core invests $1-5 million in Seed to Series A companies in financial services, healthcare, insurance, real estate, and work technology, providing hands-on partnership and strategic guidance in regulated industries.

Quantifiable outcome

• 77 million Americans served by portfolio companies
• +1 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• QED Investors: QED Investors is one of the longest-standing dedicated fintech venture firms, focused on early-stage financial services startups in the U.S. and emerging markets. It is the closest comparable to Core given parallel fintech-only thesis, Seed/Series A orientation, and operator-heavy team (founding partner Nigel Morris co-founded Capital One).
• Ribbit Capital: Ribbit Capital is a fintech-focused venture firm that invests across early- and growth-stage financial services. It targets many of the same verticals as Core (lending, insurance, payments, wealth) but operates at materially larger check sizes, making it a direct comparable on thesis and a competitor on rounds.
• Nyca Partners: Nyca Partners is a fintech-focused venture and growth fund that invests in companies rebuilding financial services infrastructure. Overlapping thesis with Core around regulated financial services, payments, and lending makes it a direct peer on category and stage.
• Anthemis: Anthemis is a venture investor and platform focused exclusively on financial services, with an emphasis on financial health and inclusion. Its mission alignment with Core's Financial Health Network origins and early-stage fintech focus make it a direct comparable.
• Forerunner: Forerunner is a consumer-focused venture firm with a heavy emphasis on fintech-adjacent categories (financial services, insurance, healthcare access). It is comparable to Core on stage, consumer fintech lens, and overlap in portfolio categories like insurance and financial access.
• F-Prime Capital: F-Prime Capital is the venture arm of Fidelity, investing broadly in fintech, healthcare, and enterprise tech. It is comparable to Core on early-stage fintech investing and on healthcare exposure, and competes on a portion of overlapping deals.

Broad incumbents

• General Catalyst: General Catalyst is a large multi-stage firm with a deep healthcare and fintech practice that overlaps heavily with Core's portfolio categories. It serves as a broader incumbent comparable — similar thesis areas, but materially larger fund sizes and broader stage coverage.
• Bain Capital Ventures: Bain Capital Ventures is the early-stage arm of Bain Capital with significant fintech and insurtech activity. It is a broad incumbent peer to Core given overlapping fintech investing themes, though it operates with much larger funds and a wider sector remit.
• Andreessen Horowitz: a16z is a leading multi-stage venture firm with dedicated fintech and bio/health funds that overlap with Core's core verticals. As a broad incumbent, it competes on the highest-quality fintech rounds but at far larger check sizes and broader sector breadth.
• Obvious Ventures: Obvious Ventures is a venture firm investing in companies addressing the world's biggest systemic challenges, with deep activity in health, financial services, and work. Its mission-driven thesis and stage focus overlap meaningfully with Core's verticals.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/therealcorevc
• LinkedInlinkedin.com/company/core-innovation-capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments122 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Core Innovation Capital